BeLiver - Reinventing Treatment Selection for Better Patient Care

Reinventing Treatment Selection for Better Patient Care

Empowering oncologists with rational
enlightened therapeutic decision

At BeLiver, we increase survival chances by providing new rational biological data, helping oncologists to select the most suitable treatment for each patient. We are developing a precision medicine platform that uncovers a tumor’s unique biology and predicts, for a specific tumor, its response probability to each treatment option.

Discover our services

Healthcare professional with a futuristic holographic projection of a liver, representing BeLiver's advanced AI-driven diagnostics for personalized liver cancer (HCC) treatment.

Cupped hands gently holding a glowing, holographic liver with digital data overlays, symbolizing BeLiver's advanced, personalized approach to liver health and HCC treatment.

High resolution proteomic profiling coupled with AI to reach precision medicine in oncology

We perform proteomic analysis on tumor biopsies and leverage AI to predict the most effective treatments for each patient. This approach not only empowers clinicians to choose optimal therapies, but also drives research toward new and improved therapeutic strategies.

Discover the science

Interested in partnering with us?

We invite all stakeholders—clinicians, researchers, pharma companies, hospitals—to join BeLiver journey and build a unified front against cancer.

Connect with us

Scientist analyzing mass spectrometry data for proteomic research and cancer biomarker discovery.

We wouldn’t be here without their support

Strategic Growth & Support Partners

Academic & Research Collaborators